'Berenil' and nitroimidazole combinations in the treatment of Trypanosoma brucei infection with central nervous system involvement.
D000578:Amidines / Q000627:therapeutic use*; D000818:Animals; D001550:Benzamidines / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000469:parasitology; D004133:Diminazene / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004996:Ethidium / Q000627:therapeutic use; D005260:Female; D007555:Isoxazoles / Q000627:therapeutic use; D051379:Mice; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D010617:Phenanthridines / Q000627:therapeutic use*; D012385:Ronidazole; D013997:Time Factors; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014346:Trypanosoma brucei brucei; D014353:Trypanosomiasis, African / Q000188:drug therapy*
C024767:3-(1-methyl-5-nitroimidazole-2-yl)-4,5-hexamethylene-delta(2)-isoxazoline; D000578:Amidines; D001550:Benzamidines; D007555:Isoxazoles; D009593:Nitroimidazoles; D010617:Phenanthridines; D014344:Trypanocidal Agents; C022191:MK 436; C004795:pyrithidium bromide; C000702:isometamidium chloride; D012385:Ronidazole; D004996:Ethidium; C003915:diminazene aceturate; D004133:Diminazene